Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The genetic variant SLC2A1 -rs1105297 is associated with the differential analgesic response to a glucose-based treatment in newborns.

Pain - 1 Mar 2024

Farinella Riccardo, Falchi Fabio, Tavanti Arianna, Tuoni Cristina, Di Nino Maria Grazia, Filippi Luca, Ciantelli Massimiliano, Rizzato Cosmeri, Campa Daniele

Abstract excerpt

ABSTRACT: Neonatal pain is a critical issue in clinical practice. The oral administration of glucose-based solutions is currently one of the most common and effective nonpharmacologic strategies for neonatal pain relief in daily minor procedures. However, a varying degree of analgesic efficacy has been reported for this treatment. Environmental, maternal, and genetic factors may explain this variability and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles
Share to Analgesics, Opioid

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glucose

Share to Glucose Transporter Type 1

Share to Infant, Newborn

Share to Pain Management

Source

Open in PubMed Open full text

Identifiers

PMID: 37703430
DOI: 10.1097/j.pain.0000000000003051
PMCID: PMC10859852

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The genetic variant SLC2A1 -rs1105297 is associated with the differential analgesic response to a glucose-based treatment in newborns.PMID 37703430Read ↗

Role of OPRM1, clinical and anthropometric variants in neonatal pain reduction.Semantic proximity Read ↗

Identifying Opioid-Related Pharmacogenomic Variants in High-Risk Hospitalized Infants: A Pilot StudySemantic proximity Read ↗

Analgesia and Opioids: A Pharmacogenetics Shortlist for Implementation in Clinical Practice.Semantic proximity Read ↗

Can pharmacogenetics inform morphine dosing in the neonatal intensive care unit? A retrospective evaluation.Semantic proximity Read ↗

Efficacy of Oral Glucose in Reducing Behavioural Responses to a Noxious Stimulus in Healthy Term NeonatesSemantic proximity Read ↗

Pharmacogenomics of opioids and perioperative pain management.Semantic proximity Read ↗

Neonatal medications.Semantic proximity Read ↗

Pharmacogenetics in obstetric anesthesia.Semantic proximity Read ↗

Association between maternal single nucleotide polymorphisms in genes regulating glucose metabolism and risk for neural tube defects in offspring.Semantic proximity Read ↗

[MODERN VIEWS ON THE PHARMACOGENETICS OF PAIN.]Semantic proximity Read ↗

Observational study of the effect of mu-opioid receptor genetic polymorphism on intrathecal opioid labor analgesia and post-cesarean delivery analgesia.Semantic proximity Read ↗

Pharmacogenetics in obstetric anesthesia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.